Laura de Arroyo Garcia Ph.D.

Associate

London + 44.20.7039.5173

Connect:

Share

Laura de Arroyo Garcia supports complex commercial and strategic advisory matters for organizations operating in the life sciences, biotechnology, medical devices, health care, and consumer sectors. She advises clients across a broad range of regulatory, intellectual property, technology, and data-related issues, including in relation to new product and service launches, commercial transactions, regulatory change, digital transformation, and the deployment of emerging technologies (including artificial intelligence, digital platforms, and Internet of Things).

Laura has a strong technical background in bioinformatics, computational biology, and synthetic biology, as well as entrepreneurial experience gained as part of an Imperial College spinout. She combines leading sector experience with rigorous academic training in the life sciences, enabling her to provide commercially informed guidance across a wide range of legal issues.

Laura serves as a committee member of the Imperial College London Research Ethics Committee, which reviews medium and high-risk research involving human participants undertaken at the college.

Laura's experience also encompasses patent litigation, information security, and digital regulation spanning adtech, online safety, and cyber regulatory matters. Prior to joining Jones Day in 2026, she spent significant time on a secondment to a global technology company and a global automotive company.

Experience

  • BioMarin acquires Alesta TherapeuticsJones Day advised BioMarin Pharmaceutical Inc. in the acquisition of Alesta Therapeutics B.V. for $275 million in upfront cash consideration, plus up to $215 million in contingent milestone payments.
  • Radiology Partners acquires Everlight RadiologyJones Day is advising Radiology Partners, Inc., the provider of technology and AI-enabled radiology services, in its acquisition of  Everlight Radiology, a leading international teleradiology provider serving hospitals, health systems and imaging centers across the United Kingdom, Ireland, Australia, New Zealand and South Africa.
  • Swift Partners acquires Argos from SainsburyJones Day is advising Swift Partners in the acquisition of Argos Limited, a leading UK general merchandise retailer, from J Sainsbury plc.
  • Doctolib acquires Medicus HealthJones Day advised Doctolib, a leading digital health unicorn, on its acquisition of Medicus Health, a London-based innovator behind the first new GP clinical software system introduced into the NHS in over 25 years.
    • View All

    May 2026 Commentary

    UK Clinical Trials Enter a New Regulatory Era

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.